Atorvastatin calcium -: Lipitor® -: Hypolipidemic -: HMG-CoA reductase inhibitor

被引:0
|
作者
不详
机构
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:963 / 964
页数:2
相关论文
共 50 条
  • [1] An overview of the clinical safety profile of atorvastatin (Lipitor), a new HMG-CoA reductase inhibitor
    Black, DM
    Bakker-Arkema, RG
    Nawrocki, JW
    ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (06) : 577 - 584
  • [4] Atorvastatin calcium: An addition to HMG-CoA reductase inhibitors
    Chong, PH
    Seeger, JD
    PHARMACOTHERAPY, 1997, 17 (06): : 1157 - 1177
  • [6] EFFECT OF FOOD ON THE BIOAVAILABILITY OF ATORVASTATIN, AN HMG-COA REDUCTASE INHIBITOR
    RADULOVIC, LL
    CILLA, DD
    POSVAR, EL
    SEDMAN, AJ
    WHITFIELD, LR
    JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 35 (10): : 990 - 994
  • [7] Atorvastatin, a potent HMG-CoA reductase inhibitor, is not antipyretic in rats
    Kamerman, PR
    Modisa, BME
    Mphahlele, NR
    JOURNAL OF THERMAL BIOLOGY, 2004, 29 (7-8) : 431 - 435
  • [8] Effect of food on the pharmacodynamics and pharmacokinetics of atorvastatin, an inhibitor of HMG-CoA reductase
    L. R. Whitfield
    R. H. Stern
    A. J. Sedman
    R. Abel
    D. M. Gibson
    European Journal of Drug Metabolism and Pharmacokinetics, 2000, 25 : 97 - 101
  • [9] DEVELOPMENTAL TOXICITY OF THE HMG-COA REDUCTASE INHIBITOR, ATORVASTATIN, IN RATS AND RABBITS
    DOSTAL, LA
    SCHARDEIN, JL
    ANDERSON, JA
    TERATOLOGY, 1994, 50 (06) : 387 - 394
  • [10] Effect of food on the pharmacodynamics and pharmacokinetics of atorvastatin, an inhibitor of HMG-CoA reductase
    Whitfield, LR
    Stern, RH
    Sedman, AJ
    Abel, R
    Gibson, DM
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2000, 25 (02) : 97 - 101